Hologic, Inc. is a developer, manufacturer, and supplier of diagnostic products, medical imaging systems, and surgical products. The Company’s core business units focus on diagnostics, breast health, gynecological surgical, and skeletal health. Its major products include the Selenia Dimension mammography system, the Discovery and Horizon bone densitometers, the NovaSure endometrial ablation device, the ThinPrep pap test, and the Aptima, Cervista, and Prodesse diagnostic assays.

Type
Public
HQ
Marlborough, US
Founded
1985
Size (employees)
6,233 (est)+17%
Hologic was founded in 1985 and is headquartered in Marlborough, US
Report incorrect company information

Key People/Management at Hologic

Stephen MacMillan

Stephen MacMillan

Chairman, President and Chief Executive Officer
Monica Berthelot

Monica Berthelot

Senior Assistant to CEO
Allison Bebo

Allison Bebo

Senior Vice President, Human Resources
Sean Daugherty

Sean Daugherty

Division President, GYN Surgical Solutions
John Griffin

John Griffin

General Counsel
Mike Kelly

Mike Kelly

Chief Supply Chain Officer and Corporate Vice President of Quality Assurance and Regulatory Affairs
Show more

Hologic Office Locations

Hologic has an office in Marlborough
Marlborough, US (HQ)
250 Campus Dr
Show all (1)
Report incorrect company information

Hologic Financials and Metrics

Hologic Financials

Hologic's revenue was reported to be $2.83 b in FY, 2016 which is a 4.7% increase from the previous period.
USD

Market capitalization (14-Jun-2018)

11 b

Closing share price (14-Jun-2018)

40.2
Hologic's current market capitalization is $11 b.
Annual
usdFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8 b2 b2.5 b2.5 b2.7 b2.8 b

Revenue growth, %

12%24%2%7%5%

Cost of goods sold

818.2 m731.3 m755.5 m756.8 m

Gross profit

1.7 b1.8 b1.9 b2.1 b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

612.4 m625 m632.6 m652.8 m655.5 m693.9 m695.2 m693.3 m717.4 m734.4 m715.4 m806.1 m

Cost of goods sold

176.9 m

Gross profit

435.6 m

Gross profit Margin, %

71%
Annual
usdY, 2010Y, 2011Y, 2012Y, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

515.6 m712.3 m560.4 m822.5 m736.1 m491.3 m548.4 m540.6 m

Accounts Receivable

325.3 m(41.5 m)

Inventories

289.4 m330.6 m283.1 m274.7 m331.6 m

Current Assets

1.6 b1.6 b1.3 b1.3 b1.5 b
Quarterly
USDQ1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

442.5 m632.5 m544 m670.5 m885 m650.3 m316.3 m441.5 m646 m1.1 b588.4 m

Inventories

301.7 m329.8 m310.3 m298.2 m295 m286.4 m285.1 m280.5 m258.3 m384 m357 m

Current Assets

1.2 b1.4 b1.3 b1.4 b1.6 b1.4 b1.1 b1.2 b2.3 b2.1 b1.5 b

PP&E

479.7 m467.4 m458.2 m451 m449.9 m454.5 m454.1 m451.5 m432.6 m482.7 m485.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(1.2 b)17.3 m131.6 m330.8 m755.5 m

Depreciation and Amortization

95.5 m94.7 m81.5 m293.4 m297.1 m

Inventories

25.2 m(45 m)43.9 m7.6 m331.6 m

Accounts Payable

(6.4 m)11.8 m25.5 m40.1 m166.6 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(5.4 m)(22.1 m)(10.8 m)29.2 m77 m106.5 m84.9 m153.8 m238.7 m86.5 m613.3 m672.8 m

Depreciation and Amortization

24.9 m49 m72.7 m20.3 m40.7 m60.8 m19.9 m40.2 m61.3 m20.4 m39.5 m63.5 m27 m52 m

Inventories

(14.2 m)(23.8 m)(42.2 m)18.7 m29 m32.9 m(3.6 m)(2.3 m)2.1 m(20.7 m)(29 m)(20.2 m)

Accounts Payable

10.4 m(12.3 m)1.7 m(24.8 m)(17.8 m)(1.8 m)(4.9 m)1.6 m14.4 m(17.8 m)500 k(28.3 m)
Show all financial metrics
Report incorrect company information

Hologic Online and Social Media Presence

Embed Graph
Report incorrect company information

Hologic News and Updates

Kidney Biopsy Market Comprehensive Analysis and Future Estimations 2023 with Trends and Future Prospects Details for Business Development

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Kidney Biopsy Market Research Report– Global Forecast till 2023” Gives industry size, top players and worldwide demand Posted via Industry Today. Follow us on Twitter @Industr…

Arteriovenous Malformation Market Top Key players- Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others through 2017-2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Arteriovenous Malformation Market Research Report - Global Forecast till 2023” Gives industry size, top players and worldwide demand Posted via Industry Today. Follow us on Tw…

Biopsy Devices Market Growth Analysis by 2020

The global biopsy devices market is expected to register a significant growth over a forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information